STOCK TITAN

Nano-X Imaging Ltd. (NASDAQ: NNOX) CEO buys 36,000 shares at $0.93

(Neutral)
(Positive)
Form Type
4

Rhea-AI Filing Summary

Nano-X Imaging Chief Executive Officer Erez Meltzer, through his wholly owned company Oud Nof, purchased 36,000 ordinary shares on July 27, 2026 at $0.93 per share, reported as indirect ownership. The report also lists existing direct holdings of 60,584 shares and several vested and vesting stock option grants with exercise prices between $2.21 and $23.84, expiring from 2030 to 2034.

Positive

  • None.

Negative

  • None.
Insider Meltzer Erez
Role Chief Executive Officer
Bought 36,000 shs ($33K)
Type Security Shares Price Value
Purchase Ordinary Shares F1 36,000 $0.93 $33K
holding Stock Option (right to buy ordinary shares) F2, F3 -- -- --
holding Stock Option (right to buy ordinary shares) F2, F4 -- -- --
holding Stock Option (right to buy ordinary shares) F2, F5 -- -- --
holding Ordinary Shares F2 -- -- --
Holdings After Transaction: Ordinary Shares — 36,000 shares (Indirect, By a wholly owned company); Stock Option (right to buy ordinary shares) — 490,234 shares (Direct); Ordinary Shares — 60,584 shares (Direct)
Footnotes (5)
  1. F1. The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.
  2. F2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
  3. F3. The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.
  4. F4. The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.
  5. F5. The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).
Shares purchased 36,000 Ordinary Shares Purchased indirectly via Oud Nof on July 27, 2026
Purchase price per share $0.93 Price per Ordinary Share for the 36,000-share purchase on July 27, 2026
Indirect shares held after purchase 36,000 Ordinary Shares Indirect ownership through a wholly owned company following the reported transaction
Direct Ordinary Shares held 60,584 Ordinary Shares Direct holdings position reported for Erez Meltzer as of the Form 4 date
Option exercise price (2030 expiry) $2.21 Stock option on 40,234 Ordinary Shares expiring February 11, 2030, fully vested and exercisable
Option exercise price (2032 expiry) $23.84 Stock option on 300,000 Ordinary Shares expiring January 2, 2032, fully vested and exercisable
Option exercise price (2034 expiry) $11.52 Stock option on 150,000 Ordinary Shares expiring April 16, 2034, vesting quarterly through April 16, 2028
indirect ownership financial
"Reported as indirect ownership through a wholly owned company"
fully vested and exercisable financial
"are fully vested and exercisable as of the date of this report"
vest on a quarterly basis financial
"an additional 6.25% of the options vest on a quarterly basis"
expiration date financial
"Stock option grants with an expiration date between 2030 and 2034"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Nano-X Imaging (NNOX) report for CEO Erez Meltzer?

A company wholly owned by CEO Erez Meltzer purchased 36,000 ordinary shares of Nano-X Imaging on July 27, 2026 at $0.93 per share, reported as indirect ownership in a Form 4 insider transaction report.

At what price did Nano-X Imaging (NNOX) shares trade in this CEO purchase?

The reported purchase was executed at $0.93 per ordinary share for 36,000 shares. The transaction is classified as a purchase by Oud Nof, a company wholly owned by the CEO, and disclosed as indirect ownership.

How many Nano-X Imaging (NNOX) shares does CEO Erez Meltzer hold directly and indirectly?

As reported, a wholly owned company holds 36,000 shares indirectly, and Meltzer is also shown with 60,584 ordinary shares held directly. Additional stock option positions on Nano-X Imaging shares are listed separately in the same Form 4.

What stock options in Nano-X Imaging (NNOX) does the CEO report?

The CEO reports stock options over 40,234 shares at $2.21 expiring February 11, 2030, 300,000 shares at $23.84 expiring January 2, 2032, and 150,000 shares at $11.52 expiring April 16, 2034, with specified vesting terms.

Is the Nano-X Imaging (NNOX) CEO purchase under a Rule 10b5-1 trading plan?

No. The Form 4’s Rule 10b5-1 checkbox is not marked, indicating the 36,000-share purchase at $0.93 was not affirmatively reported as executed under a pre-established Rule 10b5-1 trading plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Meltzer Erez

(Last)(First)(Middle)
C/O NANO-X IMAGING LTD., OFER TECH PARK
94 SHLOMO SHMELTZER ROAD

(Street)
PETACH TIKVA4927920

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nano-X Imaging Ltd. [ NNOX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/27/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/27/2026P36,000A$0.9336,000IBy a wholly owned company(1)
Ordinary Shares(2)60,584D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy ordinary shares)(2)$2.21 (3)02/11/2030Ordinary Shares40,23440,234D
Stock Option (right to buy ordinary shares)(2)$23.84 (4)01/02/2032Ordinary Shares300,000300,000D
Stock Option (right to buy ordinary shares)(2)$11.52 (5)04/16/2034Ordinary Shares150,000150,000D
Explanation of Responses:
1. The ordinary shares reported in this row were purchased by Oud Nof, a company wholly owned by the Reporting Person.
2. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
3. The options reported in this row were granted to the Reporting Person by the Issuer on February 11, 2020 and are fully vested and exercisable as of the date of this report.
4. The options reported in this row were granted to the Reporting Person by the Issuer on January 2, 2020 and are fully vested and exercisable as of the date of this report.
5. The options reported in this row were granted to the Reporting Person by the Issuer on April 16, 2024, and vest and become exercisable in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested on the four-year anniversary of that grant date (April 16, 2028).
/s/ Marina Gofman Feler, attorney-in-fact07/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)